RE:Interesting - see where this goes ...I second that; very interesting.
I great strategic move to become a specialist in MRI guided technology and not just prostate cancer. Its also nice to see that they are doing it above the current share price gpood indication they know its undervalued at current price.
Expanded market reach (MR-HIFU, as a technology, has also been shown to have clinical application in other medical conditions, including non-invasive ablation of abdominal cancers, hyperthermia for cancer therapy and palliative pain treatment of bone metastases.), expanded sales agreement with philips to sell both technologies, good long term positioning for the company, technology already approved in EU should help increase revenues/get to cash flow positive at a faster rate.
Well done - I've become slightly more positive about this story with this development. (I think this positions them even better to be taken out by a big player as they are now not just a "one trick pony" but have broader MRI applications.